市场调查报告书
商品编码
1494888
2030 年特种酵素市场预测:按类型、原产地、应用、最终用户和地区进行的全球分析Specialty Enzymes Market Forecasts to 2030 - Global Analysis By Type (Carbohydrases, Proteases, Lipases, Polymerases & Nucleases and Other Types), Source, Application, End User and By Geography |
根据 Stratistics MRC 的数据,2024 年全球特种酵素市场规模将达到 15 亿美元,预计到 2030 年将达到 25 亿美元,预测期内复合年增长率为 8.7%。
特种酶是一类具有独特性质和功能的酶,通常针对製药、诊断、食品加工和生物技术等各个行业的特定应用而量身定制。这些酵素的特点是能够在特定条件下有效催化特定反应,使其成为各种工业製程的宝贵工具。专用酶可以是人工的、精製的或天然存在的酶,通常具有高基材特异性和稳定性,使它们能够执行传统酶无法有效完成的任务。
医学和诊断需求不断增长
酵素在药物开发、製造和疾病检测中发挥重要作用,其在製药和诊断领域的需求正在迅速增加。由于其特异性和效率,酶在药物製剂中至关重要,有助于药物的合成和精製。此外,在诊断学中,酵素是各种检测套件的重要组成部分,有助于准确的疾病诊断和监测。这种不断增长的需求证实了特种酵素在推进医疗保健解决方案中发挥的关键作用,并支持市场的有希望的成长轨迹。
与传统流程的衝突
市场面临来自传统工艺的激烈竞争,构成了重大挑战。传统的製造方法通常提供熟悉且既定的通讯协定,使得特种酵素难以渗透到某些产业。此外,一些消费者认为传统工艺更可靠、更具成本效益,阻碍了市场成长。为了取得成功,特种酵素製造商必须透过展示明显的优势(例如提高效率、特异性和永续性)来说服业界采用其产品而不是传统方法。
催化作用在製造业的兴起
催化作用,即酵素等生物系统的催化作用,在市场上正在迅速成长。这种增长主要是由于它们的环保性、成本效益和高特异性。越来越多的产业正在采用生物催化剂,特别是在药品、食品和饮料以及生质燃料的生产过程中。酵素具有反应条件温和、能耗低等优点。随着人们对永续性和绿色化学的日益重视,生物催化剂在革新各行业的製造实践方面发挥关键作用。
酵素生产成本高
由于酵素生产成本高,市场面临重大挑战。这一障碍源于提取和精製过程的复杂性以及製造所需的先进技术。此外,严格的品管措施进一步推高了生产成本。这种成本上升可能会影响定价策略并降低利润率,因此需要创新的解决方案来优化生产效率并提高成本效益,从而限制市场成长。
由于 COVID-19,市场正在发生变化。在最初因供应链和製造中断导致生产放缓后,对诊断套件的酵素的需求增加,对 COVID-19治疗方法的研究激增。随着疫情的发展,健康意识的转变正在推动药品、食品和生技领域对酵素的需求。市场正在适应新的规范,专注于抗病毒酶研究,探索疫苗开发和诊断技术的机会,形成一个有弹性和不断发展的格局。
预计微生物酶领域在预测期内将是最大的
微生物酶预计在预测期内达到高峰。其应用范围广泛,包括食品和饮料加工、製药、纺织产品和生质燃料生产。淀粉酶、蛋白酶、脂肪酶和纤维素酶等关键微生物酶由于能够精确催化特定反应而非常受欢迎。在生物技术进步和对永续解决方案日益增长的需求的推动下,微生物酶继续主导特种酶市场,推动创新并满足多样化的工业需求。
预计製药业在预测期内复合年增长率最高
预计製药业在预测期内复合年增长率最高。这些酵素在药物製造的各个阶段发挥着至关重要的作用,包括药物配方、合成和精製过程。它对于提高药品生产的效率、特异性和产量至关重要,从而促进新药和生物製药的开发。该领域正在进行不断的创新和研究,以满足製药业对具有先进功能的高品质酵素不断变化的需求。
在食品、饮料和生物技术等各个行业需求不断增长的推动下,预计北美在预测期内将占据最大的市场占有率。技术进步、消费者健康意识的提高以及特种酶应用的扩大等因素正在推动市场扩张。专注于创新和永续性,主要企业正在积极投资研发,以推出新型酵素产品并提高其市场占有率。
预计亚太地区在预测期内将维持最高的复合年增长率。该地区不断上涨的医疗成本和慢性病的流行正在推动对用于药品製造流程、诊断套件和治疗的专用酵素的需求。酶工程和生物技术的进步导致了性能改进的新型酶的开发。这些进步正在推动跨行业采用专用酶并促进市场成长。
According to Stratistics MRC, the Global Specialty Enzymes Market is accounted for $1.5 billion in 2024 and is expected to reach $2.5 billion by 2030 growing at a CAGR of 8.7% during the forecast period. Specialty enzymes are a class of enzymes that exhibit unique properties and functions, often tailored for specific applications in various industries such as pharmaceuticals, diagnostics, food processing, and biotechnology. These enzymes are characterized by their ability to catalyze specific reactions efficiently under specific conditions, making them valuable tools for various industrial processes. Specialty enzymes may be engineered, purified, or naturally occurring, and they typically possess high substrate specificity and stability, enabling them to perform tasks that conventional enzymes cannot accomplish effectively.
Growing demand in pharmaceuticals & diagnostics
The market is witnessing burgeoning demand in pharmaceuticals and diagnostics sectors due to their vital roles in drug development, production, and disease detection. Enzymes' specificity and efficiency make them indispensable in pharmaceutical formulations, aiding in drug synthesis and purification. Moreover, in diagnostics, enzymes serve as crucial components in various assay kits, facilitating accurate disease diagnosis and monitoring. This escalating demand underscores the pivotal role specialty enzymes play in advancing healthcare solutions and underscores the market's promising growth trajectory.
Competition from traditional processes
The market faces stiff competition from traditional processes, posing significant challenges. Traditional methods often offer familiarity and established protocols, making it challenging for specialty enzymes to penetrate certain industries. Moreover, some consumers may perceive traditional processes as more reliable or cost-effective, hindering the market's growth. To thrive, specialty enzyme manufacturers must showcase distinct advantages such as enhanced efficiency, specificity, and sustainability to convince industries to adopt their products over conventional methods.
Rise of biocatalysis in manufacturing
Biocatalysis is catalysis through biological systems like enzymes, and it's experiencing a surge in the market. This rise is primarily due to its eco-friendly nature, cost-effectiveness, and high specificity. Industries are increasingly adopting biocatalysis in manufacturing processes, especially in pharmaceuticals, food and beverages, and biofuels. Enzymes offer advantages like mild reaction conditions and reduced energy consumption. With growing emphasis on sustainability and green chemistry, biocatalysis is poised to play a pivotal role in revolutionizing manufacturing practices across various sectors.
High cost of enzyme production
The market faces a significant challenge due to the high cost of enzyme production. This hurdle arises from the complexities involved in the extraction and purification processes, as well as the sophisticated technologies required for manufacturing. Additionally, stringent quality control measures further add to the production expenses. These elevated costs can limit market growth by influencing pricing strategies and potentially reducing profit margins, necessitating innovative solutions to optimize production efficiency and enhance cost-effectiveness.
The market has witnessed shifts due to COVID-19. While initially, disruptions in supply chains and manufacturing slowed down production, increased demand for enzymes in diagnostic kits and research for COVID-19 treatments surged. As the pandemic progresses, a shift towards health consciousness has boosted demand for enzymes in pharmaceuticals, nutraceuticals, and biotechnology. The market is adapting to new norms, emphasizing research in antiviral enzymes and exploring opportunities in vaccine development and diagnostic technologies, shaping a resilient and evolving landscape.
The microbial enzymes segment is expected to be the largest during the forecast period
The microbial enzymes is expected to be the largest during the forecast period. Their wide-ranging applications include food and beverage processing, pharmaceuticals, textiles, and biofuel production. Key microbial enzymes such as amylase, protease, lipase, and cellulase are highly sought after for their ability to catalyze specific reactions with precision. With advancements in biotechnology and increasing demand for sustainable solutions, microbial enzymes continue to dominate the specialty enzymes market, driving innovation and meeting diverse industrial needs.
The pharmaceuticals segment is expected to have the highest CAGR during the forecast period
The pharmaceuticals segment is expected to have the highest CAGR during the forecast period. These enzymes play pivotal roles in various stages of pharmaceutical manufacturing, including drug formulation, synthesis, and purification processes. They are vital for enhancing efficiency, specificity, and yield in pharmaceutical production, thereby facilitating the development of novel drugs and biopharmaceuticals. This sector witnesses continuous innovation and research to meet the evolving demands of the pharmaceutical industry for high-quality enzymes with advanced functionalities.
North America is projected to hold the largest market share during the forecast period driven by increasing demand across various industries such as food and beverages and biotechnology. Factors such as technological advancements, growing consumer awareness regarding health and wellness, and the expanding applications of specialty enzymes are fueling market expansion. With a focus on innovation and sustainability, key players are actively investing in research and development to introduce novel enzyme products, thereby enhancing their market presence.
Asia Pacific is projected to hold the highest CAGR over the forecast period. With the rise in healthcare expenditure and the prevalence of chronic diseases in the region, there's a growing demand for specialty enzymes used in drug manufacturing processes, diagnostic kits, and therapeutic treatments. Advances in enzyme engineering and biotechnology have led to the development of novel enzymes with improved performance characteristics. These advancements are driving the adoption of specialty enzymes across industries, contributing to market growth.
Key players in the market
Some of the key players in Specialty Enzymes market include Novozymes, DuPont , BASF SE, Roche Holding AG, Codexis Inc., Advanced Enzyme Technologies Ltd., Amano Enzyme Inc., AB Enzymes GmbH, Biocatalysts Ltd., Dyadic International Inc., Enzyme Development Corporation, DSM Nutritional Products AG, Aumgene Biosciences, Lonza Group Ltd., BBI Enzymes Ltd., Creative Enzymes and Enzyme Solutions Inc.
In October 2023, BASF strengthened its enzyme technology for detergents and cleaners with the launch of a new enzymes' generation from its Lavergy(R) portfolio. hese offers are part of BASF's Care Chemicals Initiative Care 360° - Solutions for Sustainable Life, the division's cross-business and holistic approach to cover all topics impacting the future of key markets and industries: sustainability, digitalization, innovation, and new approaches to working together.
In February 2023, AB Enzymes and Barentz announced the extension of the distribution agreement for our bake & food enzymes in most of Europe with Barentz. Besides the VERON(R) baking enzymes for bread improver and premix manufacturers, flour mills, biscuit, cracker, wafer, noodles and pasta they will also focus on the distribution of our food enzymes portfolio for protein processing and modification as well as grain and fruit processing.
Market Outlook, By Type (2022-2030) ($MN)